Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TQB3455
i
Other names:
TQB3455
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Sino Biopharm
Drug class:
IDH2 inhibitor
Related drugs:
‹
enasidenib (16)
vorasidenib (6)
LY3410738 (1)
NMS-173 (1)
AGI-6780 (0)
HMPL-306 (0)
SH1573 (0)
enasidenib (16)
vorasidenib (6)
LY3410738 (1)
NMS-173 (1)
AGI-6780 (0)
HMPL-306 (0)
SH1573 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH2 R172K
Acute Myelogenous Leukemia
IDH2 R172K
Acute Myelogenous Leukemia
TQB3455
Sensitive: C3 – Early Trials
TQB3455
Sensitive
:
C3
TQB3455
Sensitive: C3 – Early Trials
TQB3455
Sensitive
:
C3
IDH2 mutation
Acute Myelogenous Leukemia
IDH2 mutation
Acute Myelogenous Leukemia
TQB3455
Sensitive: C3 – Early Trials
TQB3455
Sensitive
:
C3
TQB3455
Sensitive: C3 – Early Trials
TQB3455
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login